BIOSIMILARS: MARKET ACCESS AND MARKET PENETRATION - A COMPARISON OF FRANCE AND GERMANY

被引：0
|
作者：
Freiberg, M. [1 ]
Schwarz, R. [1 ]
Khoury, C. [2 ]
机构：
[1] Quintiles Commercial Germany GmbH, Mannheim, Germany
[2] Quintiles Advisory Serv, St Ouen, France
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.553
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP16
引用
收藏
页码：A442 / A442
页数：1
相关论文
共 50 条
  • [41] REALITY IN MARKET ACCESS IN GERMANY AND FRANCE - COMPARATIVE ANALYSIS OF ADDED BENEFIT DECISIONS ON INNOVATIVE PHARMACEUTICAL THERAPIES
    Droeschel, D.
    Chicoye, A.
    Lepretre, M.
    VALUE IN HEALTH, 2014, 17 (07) : A440 - A441
  • [42] Market Structure and Market Access
    Francois, Joseph
    Wooton, Ian
    WORLD ECONOMY, 2010, 33 (07): : 873 - 893
  • [43] Biosimilars accessible in the market for the treatment of cancer
    Ditani, Aayushi S.
    Mallick, Pragyan Paramita
    Anup, Neelima
    Tambe, Vishakha
    Polaka, Suryanarayana
    Sengupta, Pinaki
    Rajpoot, Kuldeep
    Tekade, Rakesh K.
    JOURNAL OF CONTROLLED RELEASE, 2021, 336 : 112 - 129
  • [44] Amgen's move into the biosimilars market
    不详
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2014, 3 (04): : 202 - 203
  • [45] Current Market and Regulatory Landscape of Biosimilars
    Bhatt, Valkal
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (21): : S451 - S456
  • [46] The global biosimilars market: a look forward
    Spar, Elizabeth N.
    Wintner, Tom
    CHIMICA OGGI-CHEMISTRY TODAY, 2013, 31 (02) : 36 - 39
  • [47] Biosimilars shake up the biologics market
    Brown, KD
    GENETIC ENGINEERING NEWS, 2005, 25 (21): : 48 - +
  • [48] DIRECT MARKET ACCESS FOR MEDECINES: ANALYSIS OF ELIGIBLE PRODUCTS IN FRANCE AND COMPARISON WITH CURRENT GERMAN SYSTEM
    Linglois, N.
    Villemur, L.
    VALUE IN HEALTH, 2022, 25 (12) : S317 - S317
  • [49] CHALLENGES AND OPPORTUNITIES IN THE BIOLOGICALS-BIOSIMILARS MARKET: SUSTAINABILITY AND MARKET DIFFERENTIATION
    Garcia-Goni, M.
    Cantarero, D.
    VALUE IN HEALTH, 2018, 21 : S172 - S172
  • [50] Barriers to market uptake of biosimilars in the US
    Felix, Abigail E.
    Gupta, Anumeha
    Cohen, Joshua P.
    Riggs, Kim
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2014, 3 (03): : 108 - 115
12345